Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MSTLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Morgan Stanley's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Morgan Stanley's regulatory disclosures and financial reporting.
Form 144 for MS reports a planned insider sale of common stock. A holder has filed notice of intent to sell 30,330 shares of Morgan Stanley common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 01/20/2026. The aggregate market value of the planned sale is stated as $5,569,085.41. The shares were acquired on 01/16/2025 as an employee stock unit award from the issuer, with payment also dated 01/16/2025 and described as an employee stock unit award. Shares of common stock outstanding are reported as 1,589,309,311, providing a baseline for the size of the transaction relative to the company.
A shareholder filed a notice under Rule 144 to sell 8,500 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/20/2026 on the NYSE. The planned sale has an aggregate market value of $1,547,685.95, based on the figures in the filing. The shares were acquired on 01/16/2026 as an employee stock unit award from the issuer, and the table notes a total of 1,589,309,311 shares of the class outstanding.
A holder filed a notice under Rule 144 to sell 3,080 shares of common stock through Morgan Stanley & Co. LLC on or about 01/20/2026 on the NYSE. The filing lists an aggregate market value of $570,311.46 for these shares and notes that 1,589,309,311 shares of this class were outstanding at the time. The shares were acquired for cash on 01/09/2026. By signing, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Morgan Stanley director reported receiving additional equity compensation in the form of deferred stock units. On 12/01/2025, the reporting person acquired 459.241 shares of Morgan Stanley common stock at a price of $168.757 per share, bringing total directly owned shares to 88,666.394.
The units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for service on the Board of Directors. Each deferred stock unit is convertible into one share of common stock, aligning director compensation with shareholder interests through equity rather than cash.
Morgan Stanley director reports deferred stock unit grant tied to service on the company’s board. On 12/01/2025, the director acquired 429.612 shares of Morgan Stanley common stock in the form of deferred stock units at a price of $168.757 per share. These units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for board service and are convertible into common stock on a 1-to-1 basis.
Following this grant, the director beneficially owns 45,137.158 shares of Morgan Stanley common stock in direct form. The filing reflects a routine equity-based compensation transaction for a board member rather than an open-market purchase or sale.
Morgan Stanley director reports deferred stock unit grant
A Morgan Stanley director filed a Form 4 reporting an award of 227.151 deferred stock units of Morgan Stanley common stock on 12/01/2025. The units were acquired at a price of $168.757 per share and increased the director’s beneficial ownership to 1,895.761 shares held directly.
The filing explains that these deferred stock units were granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers for serving on the Board of Directors. Each stock unit is convertible into one share of Morgan Stanley common stock.
Morgan Stanley (MS) reported an insider transaction on Form 4. A director disclosed a disposition coded “G” of 1,800 shares of Common Stock on 11/07/2025 at a reported price of $0. Following this transaction, the reporting person beneficially owns 46,883.484 shares, held directly.
The filing indicates the form was submitted by an attorney-in-fact. No derivative securities were reported in Table II.
Morgan Stanley (MS): Schedule 13D/A (Amendment No. 21) filed by Mitsubishi UFJ Financial Group, Inc. (MUFG). MUFG reports beneficial ownership of 380,010,887 shares of Morgan Stanley common stock, representing 23.91% of the class. The filing date of the event is November 3, 2025, with share counts measured as of October 29, 2025.
The percentage is based on 1,589,309,311 shares outstanding as of October 31, 2025, as reported by Morgan Stanley. MUFG’s total includes 2,925,720 “Managed Shares” held by certain affiliates in a fiduciary capacity; MUFG disclaims beneficial ownership of these Managed Shares. MUFG indicates sole voting and sole dispositive power and no shared voting or dispositive power. The amendment also updates background details on MUFG and references historical agreements and amendments between MUFG and Morgan Stanley.
Morgan Stanley posted strong third-quarter 2025 results, with net revenues of $18.2 billion and net income of $4.6 billion, up 18% and 45% from a year earlier. Diluted EPS rose 49% to $2.80, while return on equity reached 18.0% and ROTCE was 23.5%.
All three business segments contributed: Institutional Securities revenues climbed 25% to $8.5 billion on stronger Equity trading and a rebound in Investment Banking; Wealth Management revenues grew 13% to $8.2 billion with a 30.3% pre-tax margin and $81 billion of net new assets; Investment Management revenues increased 13% to $1.7 billion.
For the first nine months of 2025, net revenues were $52.8 billion, up 16%, and net income was $12.5 billion, up 29%. The firm reported a Standardized CET1 capital ratio of 15.1% and a supplementary leverage ratio of 5.5%, alongside average liquidity resources of $368.1 billion.
Morgan Stanley (MS) filed a Form 4 for its Co‑President reporting a bona fide gift of common stock. On 10/29/2025, the insider disposed of 10,000 shares of Common Stock at $0 per share under transaction code G (gift).
Following the transaction, the insider beneficially owns 383,757.251 shares directly. In addition, 1,784.419 shares are held indirectly by a 401(k) Plan. This filing reflects a transfer by gift rather than an open-market sale.